Status:

TERMINATED

Advanced MR Imaging in Patients With Painful, Degenerative Disc Disease: A Pilot Study

Lead Sponsor:

University of California, San Francisco

Collaborating Sponsors:

National Institutes of Health (NIH)

Conditions:

Degenerative Disc Disease

Eligibility:

All Genders

25-60 years

Brief Summary

In this study, we will use advanced and newly available MR imaging techniques at 3 Tesla (including in situ axial loading and quantitative T1rho, T2, and diffusion measurements) to assess the interver...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for Patient with classic discogenic back pain:
  • age range 25-60 years old
  • Back and/or leg (back\>leg) pain
  • Degenerative disc disease in one or more adjacent vertebral levels between L3-S1
  • Radiologic confirmation of degenerative disc disease:
  • Segmental instability (3 mm translation or 5 degree angulation)
  • Decreased disc height \>2 mm
  • Scarring, thickening of annulus fibrosis
  • Vacuum phenomenon
  • No significant foraminal stenosis and nerve root compression
  • Failed observative treatment for at least 6 months
  • Oswestry LB disability questionnaire score of at least 20/50 (40%) (interpreted as moderate to severe disability)
  • Psychosocially and mentally normal
  • Patients who are scheduled for back surgery
  • Inclusion criteria for patients with degenerative disc disease without the classic discogenic back pain:
  • Age range 25-60 years old
  • Patients with diagnosis of idiopathic scoliosis, spondylolysis, or spondylolisthesis
  • Inclusion criteria for normal controls:
  • No symptoms
  • Age range 25-60 years old
  • Inclusion Criteria for post-surgical discectomy patients:
  • Patients who had successful disc surgery for lumbar herniated disc and no further back pain
  • Patients who had unsuccessful disc surgery for lumbar herniated disc and still with residual back pain
  • Exclusion Criteria:
  • prior back surgery (except as mentioned above)
  • spine fractures
  • Radiographic confirmation of facet joint disease or degeneration
  • Radiographic confirmation of sacroiliac joint pathology
  • Lytic spondylolisthesis of spinal stenosis
  • Degenerative spondylolisthesis of \> grade 1
  • Metabolic bone disease
  • Spine infection , osteomyelitis
  • Rheumatoid arthritis or any other systemic or autoimmune disease
  • Active malignancy
  • MRI Contraindications (fragment in eye, aneurysms clips, ear implants, spinal nerve stimulators, pacemaker, claustrophobia, or pregnant women, etc.,)

Exclusion

    Key Trial Info

    Start Date :

    March 1 2005

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2009

    Estimated Enrollment :

    53 Patients enrolled

    Trial Details

    Trial ID

    NCT00706459

    Start Date

    March 1 2005

    End Date

    December 1 2009

    Last Update

    November 14 2012

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of California, San Francisco

    San Francisco, California, United States, 94133